Your shopping cart is currently empty

iNOS/COX-2-IN-3 (compound 7d) is a dual inhibitor of iNOS and COX-2, demonstrating potential anti-inflammatory activity in LPS-induced RAW 264.7 cells (IC50=3.48 μM). This compound exhibits good plasma stability, oral activity, and gastric safety. Its inhibitory effects on iNOS and COX-2 expressions are 5.43 times and 2.37 times higher than those of Indomethacin, respectively.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | iNOS/COX-2-IN-3 (compound 7d) is a dual inhibitor of iNOS and COX-2, demonstrating potential anti-inflammatory activity in LPS-induced RAW 264.7 cells (IC50=3.48 μM). This compound exhibits good plasma stability, oral activity, and gastric safety. Its inhibitory effects on iNOS and COX-2 expressions are 5.43 times and 2.37 times higher than those of Indomethacin, respectively. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.